

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Re-highlighting the action of PPAR&gamma; in... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1127/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1127" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Re-highlighting the action of PPARÎ³ in treating metabolic diseases" />
    
            <meta name="og:title" content="F1000Research Article: Re-highlighting the action of PPAR&gamma; in treating metabolic diseases.">
            <meta name="og:description" content="Read the latest article version by Sung Hee Choi, Sung Soo Chung, Kyong Soo Park, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15376">
            <meta name="article-id" content="14136">
            <meta name="dc.title" content="Re-highlighting the action of PPAR&gamma; in treating metabolic diseases">
            <meta name="dc.description" content="Peroxisome proliferator-activated receptor &gamma; (PPAR&gamma;) is a member of the nuclear receptor family and plays an important role in adipocyte differentiation, glucose homeostasis, and insulin sensitivity. Thiazolidinediones (TZDs), synthetic ligands of PPAR&gamma;, have been used for the treatment of diabetes mellitus for two decades. TZDs were expected to be amazing drugs not only for type 2 diabetes but also for metabolic syndrome and atherosclerotic vascular disease because they can reduce both insulin resistance and inflammation in experimental studies. However, serious unwanted effects pushed TZDs back to an optional second-tier drug for type 2 diabetes. Nevertheless, PPAR&gamma; is still one of the most important targets for the treatment of insulin resistance and diabetes mellitus, and novel strategies to modulate PPAR&gamma; activity to enhance its beneficial effects and reduce unwanted adverse effects are anticipated. Recent studies showed that post-translational modification (PTM) of PPAR&gamma; regulates PPAR&gamma; activity or stability and may be a novel way to optimize PPAR&gamma; activity with reduced adverse effects. In this review, we will focus on recent advances in PTM of PPAR&gamma; and the mechanisms regulating PPAR&gamma; function as well as in the development of PPAR&gamma; modulators or agonists.">
            <meta name="dc.subject" content="PPARgamma, post-translational modification, metabolic disease">
            <meta name="dc.creator" content="Choi, Sung Hee">
            <meta name="dc.creator" content="Chung, Sung Soo">
            <meta name="dc.creator" content="Park, Kyong Soo">
            <meta name="dc.date" content="2018/07/24">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14136.1">
            <meta name="dc.source" content="F1000Research 2018 7:1127">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="PPARgamma">
            <meta name="prism.keyword" content="post-translational modification">
            <meta name="prism.keyword" content="metabolic disease">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/07/24">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1127">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14136.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1127">
            <meta name="citation_title" content="Re-highlighting the action of PPAR&gamma; in treating metabolic diseases">
            <meta name="citation_abstract" content="Peroxisome proliferator-activated receptor &gamma; (PPAR&gamma;) is a member of the nuclear receptor family and plays an important role in adipocyte differentiation, glucose homeostasis, and insulin sensitivity. Thiazolidinediones (TZDs), synthetic ligands of PPAR&gamma;, have been used for the treatment of diabetes mellitus for two decades. TZDs were expected to be amazing drugs not only for type 2 diabetes but also for metabolic syndrome and atherosclerotic vascular disease because they can reduce both insulin resistance and inflammation in experimental studies. However, serious unwanted effects pushed TZDs back to an optional second-tier drug for type 2 diabetes. Nevertheless, PPAR&gamma; is still one of the most important targets for the treatment of insulin resistance and diabetes mellitus, and novel strategies to modulate PPAR&gamma; activity to enhance its beneficial effects and reduce unwanted adverse effects are anticipated. Recent studies showed that post-translational modification (PTM) of PPAR&gamma; regulates PPAR&gamma; activity or stability and may be a novel way to optimize PPAR&gamma; activity with reduced adverse effects. In this review, we will focus on recent advances in PTM of PPAR&gamma; and the mechanisms regulating PPAR&gamma; function as well as in the development of PPAR&gamma; modulators or agonists.">
            <meta name="citation_description" content="Peroxisome proliferator-activated receptor &gamma; (PPAR&gamma;) is a member of the nuclear receptor family and plays an important role in adipocyte differentiation, glucose homeostasis, and insulin sensitivity. Thiazolidinediones (TZDs), synthetic ligands of PPAR&gamma;, have been used for the treatment of diabetes mellitus for two decades. TZDs were expected to be amazing drugs not only for type 2 diabetes but also for metabolic syndrome and atherosclerotic vascular disease because they can reduce both insulin resistance and inflammation in experimental studies. However, serious unwanted effects pushed TZDs back to an optional second-tier drug for type 2 diabetes. Nevertheless, PPAR&gamma; is still one of the most important targets for the treatment of insulin resistance and diabetes mellitus, and novel strategies to modulate PPAR&gamma; activity to enhance its beneficial effects and reduce unwanted adverse effects are anticipated. Recent studies showed that post-translational modification (PTM) of PPAR&gamma; regulates PPAR&gamma; activity or stability and may be a novel way to optimize PPAR&gamma; activity with reduced adverse effects. In this review, we will focus on recent advances in PTM of PPAR&gamma; and the mechanisms regulating PPAR&gamma; function as well as in the development of PPAR&gamma; modulators or agonists.">
            <meta name="citation_keywords" content="PPARgamma, post-translational modification, metabolic disease">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Sung Hee Choi">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea">
            <meta name="citation_author" content="Sung Soo Chung">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea">
            <meta name="citation_author_institution" content="Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea">
            <meta name="citation_author" content="Kyong Soo Park">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea">
            <meta name="citation_author_institution" content="Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea">
            <meta name="citation_publication_date" content="2018/07/24">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1127">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14136.1">
            <meta name="citation_firstpage" content="1127">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1127/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1127.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15376 /> <input type=hidden id=articleId name=articleId value=14136 /> <input type=hidden id=xmlUrl value="/articles/7-1127/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1127-v1.xml"> <input type=hidden id=article_uuid value=02685d68-731b-4012-b91c-ee876623d22c /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Re-highlighting the action of PPARÎ³ in treating metabolic diseases"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14136.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14136.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1127"
  },
  "headline": "Re-highlighting the action of PPARÎ³ in treating metabolic diseases",
  "datePublished": "2018-07-24T12:32:20",
  "dateModified": "2018-07-24T12:32:20",
  "author": [
    {
      "@type": "Person",
      "name": "Sung Hee Choi"
    },    {
      "@type": "Person",
      "name": "Sung Soo Chung"
    },    {
      "@type": "Person",
      "name": "Kyong Soo Park"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Peroxisome proliferator-activated receptor &gamma; (PPAR&gamma;) is a member of the nuclear receptor family and plays an important role in adipocyte differentiation, glucose homeostasis, and insulin sensitivity. Thiazolidinediones (TZDs), synthetic ligands of PPAR&gamma;, have been used for the treatment of diabetes mellitus for two decades. TZDs were expected to be amazing drugs not only for type 2 diabetes but also for metabolic syndrome and atherosclerotic vascular disease because they can reduce both insulin resistance and inflammation in experimental studies. However, serious unwanted effects pushed TZDs back to an optional second-tier drug for type 2 diabetes. Nevertheless, PPAR&gamma; is still one of the most important targets for the treatment of insulin resistance and diabetes mellitus, and novel strategies to modulate PPAR&gamma; activity to enhance its beneficial effects and reduce unwanted adverse effects are anticipated. Recent studies showed that post-translational modification (PTM) of PPAR&gamma; regulates PPAR&gamma; activity or stability and may be a novel way to optimize PPAR&gamma; activity with reduced adverse effects. In this review, we will focus on recent advances in PTM of PPAR&gamma; and the mechanisms regulating PPAR&gamma; function as well as in the development of PPAR&gamma; modulators or agonists."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1127.html",
            "name": "Re-highlighting the action of PPARÎ³ in treating metabolic diseases"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Re-highlighting the action of PPARÎ³ in treating metabolic diseases </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15376 data-id=14136 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14136.1" data-recommended="" data-doi="10.12688/f1000research.14136.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1127/v1/pdf?article_uuid=02685d68-731b-4012-b91c-ee876623d22c" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14136-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14136-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14136-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Choi SH, Chung SS and Park KS. Re-highlighting the action of PPARÎ³ in treating metabolic diseases [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1127 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14136.1" target=_blank>https://doi.org/10.12688/f1000research.14136.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14136-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14136 id=track-article-signin-14136 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14136?target=/articles/7-1127.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15376 /> <input name=articleId type=hidden value=14136 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Re-highlighting the action of PPARÎ³ in treating metabolic diseases</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Sung Hee Choi<sup>1,2</sup>,&nbsp;</span><span class="">Sung Soo Chung<sup>1,3</sup>,&nbsp;</span><span class=""><a href="mailto:kspark@snu.ac.kr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Kyong Soo Park</span></a><a href="https://orcid.org/0000-0003-3597-342X" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3597-342X</div><sup>1,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Sung Hee Choi<sup>1,2</sup>,&nbsp;</span><span class="">Sung Soo Chung<sup>1,3</sup>,&nbsp;</span><span class=""><a href="mailto:kspark@snu.ac.kr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Kyong Soo Park</span></a><a href="http://orcid.org/0000-0003-3597-342X" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3597-342X</div><sup>1,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 24 Jul 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14136.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea<br/> <sup>2</sup> Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea<br/> <sup>3</sup> Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea<br/> <sup>4</sup> Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea<br/> <p> <div class=margin-bottom> Sung Hee Choi <br/> <span>Roles: </span> Conceptualization, Data Curation, Resources, Writing â Original Draft Preparation, Writing â Review & Editing </div> <div class=margin-bottom> Sung Soo Chung <br/> <span>Roles: </span> Conceptualization, Data Curation, Resources, Supervision, Writing â Original Draft Preparation </div> <div class=margin-bottom> Kyong Soo Park <br/> <span>Roles: </span> Conceptualization, Data Curation, Resources, Supervision, Writing â Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36609-36080></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20010-36081></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Peroxisome proliferator-activated receptor Î³ (PPARÎ³) is a member of the nuclear receptor family and plays an important role in adipocyte differentiation, glucose homeostasis, and insulin sensitivity. Thiazolidinediones (TZDs), synthetic ligands of PPARÎ³, have been used for the treatment of diabetes mellitus for two decades. TZDs were expected to be amazing drugs not only for type 2 diabetes but also for metabolic syndrome and atherosclerotic vascular disease because they can reduce both insulin resistance and inflammation in experimental studies. However, serious unwanted effects pushed TZDs back to an optional second-tier drug for type 2 diabetes. Nevertheless, PPARÎ³ is still one of the most important targets for the treatment of insulin resistance and diabetes mellitus, and novel strategies to modulate PPARÎ³ activity to enhance its beneficial effects and reduce unwanted adverse effects are anticipated. Recent studies showed that post-translational modification (PTM) of PPARÎ³ regulates PPARÎ³ activity or stability and may be a novel way to optimize PPARÎ³ activity with reduced adverse effects. In this review, we will focus on recent advances in PTM of PPARÎ³ and the mechanisms regulating PPARÎ³ function as well as in the development of PPARÎ³ modulators or agonists. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> PPARgamma, post-translational modification, metabolic disease </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Kyong Soo Park (<a href="mailto:kspark@snu.ac.kr">kspark@snu.ac.kr</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Kyong Soo Park </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by National Research Foundation Grant by Ministry of Science and ICT, Republic of Korea (NRF-2016R1A2B3010373). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; Â© 2018 Choi SH <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Choi SH, Chung SS and Park KS. Re-highlighting the action of PPARÎ³ in treating metabolic diseases [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1127 (<a href="https://doi.org/10.12688/f1000research.14136.1" target=_blank>https://doi.org/10.12688/f1000research.14136.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 24 Jul 2018, <b>7</b>(F1000 Faculty Rev):1127 (<a href="https://doi.org/10.12688/f1000research.14136.1" target=_blank>https://doi.org/10.12688/f1000research.14136.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 24 Jul 2018, <b>7</b>(F1000 Faculty Rev):1127 (<a href="https://doi.org/10.12688/f1000research.14136.1" target=_blank>https://doi.org/10.12688/f1000research.14136.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d30534e202>Introduction</h2><p class="" id=d30534e205>Insulin resistance is the key pathophysiologic abnormality of many metabolic diseases such as type 2 diabetes mellitus, obesity, dyslipidemia, and cardiovascular diseases<sup><a href="#ref-1">1</a></sup>. Therefore, reducing insulin resistance is the most important strategy for improving metabolic deterioration. Thiazolidinediones (TZDs), peroxisome proliferator-activated receptor Î³ (PPARÎ³) agonists, have shown many beneficial effects not only by enhancing insulin sensitivity but also by demonstrating anti-inflammatory and antioxidant properties, whose actions are related to anti-atherosclerosis<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Thus, TZDs were considered a magic bullet for the treatment of type 2 diabetes and atherosclerosis. Indeed, TZDs demonstrated a preventive role for recurrent ischemic stroke in several clinical trials<sup><a href="#ref-4">4</a></sup> and for restenosis after percutaneous coronary intervention (PCI)<sup><a href="#ref-5">5</a>â<a href="#ref-7">7</a></sup>. However, TZDs increased the risk of peripheral edema, bone loss, and congestive heart failure<sup><a href="#ref-8">8</a>â<a href="#ref-10">10</a></sup>. A meta-analysis of clinical trials showed that rosiglitazone significantly increased the risk of myocardial infarction<sup><a href="#ref-11">11</a></sup>. Although later studies revealed that rosiglitazone did not increase the risk of heart attack and the US Food and Drug Administration (FDA) removed the warning labels from rosiglitazone-containing drugs regarding the issue of increasing heart attack in 2013, rosiglitazoneâs cardiovascular safety issue alongside the above-mentioned adverse effects still lead to many physicians hesitating to prescribe TZDs in their clinical practice. Nevertheless, PPARÎ³ is still one of the most important targets for the treatment of insulin resistance and type 2 diabetes, and novel strategies to modulate PPARÎ³ activity to enhance its beneficial effects and reduce unwanted adverse effects are strongly anticipated. Recent studies showed that post-translational modification (PTM) of PPARÎ³ regulates PPARÎ³ activity or stability and may be a novel way to optimize PPARÎ³ activity with reduced adverse effects. In addition, selective PPARÎ³ modulators (sPPAR<i>Î³</i>Ms), dual or pan PPAR agonists, have been developed and tested for their metabolic effects in animal studies and in some clinical trials.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d30534e248>PPARÎ³, a therapeutic target for insulin resistance (<a href="#f1">Figure 1</a>)</h2><p class="" id=d30534e254>PPARÎ³ is a master regulator of adipocyte differentiation. It is also involved in glucose homeostasis and insulin sensitivity. The expression of PPARÎ³ is most abundant in adipose tissue<sup><a href="#ref-12">12</a></sup>. Evidence has shown that the primary target of TZDs is adipose tissue, where it increases the expression of Glut4 and CAP<sup><a href="#ref-13">13</a></sup>, and an animal model lacking PPARÎ³ in adipose tissue had a significantly lower response to TZDs<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. TZDs inhibit the expression of TNF-Î±, IL-6, and resistin in adipose tissue, which promote insulin resistance and chronic inflammation<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup>, while TZDs increased the production of adiponectin and fibroblast growth factor 21 (FGF21), which enhance fatty acid oxidation and insulin sensitivity<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. TZDs increase lipogenesis by aP2, LPL, CD36, fatty acid transport protein, PEPCK, and the glycerol transporter aquaporin 7<sup><a href="#ref-2">2</a></sup> and make adipose tissue store more lipid, while TZDs remove lipid accumulation in other tissues such as muscle and liver<sup><a href="#ref-20">20</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/15376/9ba0d516-292a-4325-a3e3-f3ebac85148d_figure1.gif"><img alt="9ba0d516-292a-4325-a3e3-f3ebac85148d_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/15376/9ba0d516-292a-4325-a3e3-f3ebac85148d_figure1.gif"></a><div class=caption><h3>Figure 1. Effect of PPARÎ³ activation on various tissues.</h3><p id=d30534e305>ACSL1, acyl-CoA synthetase long chain family member 1; CD36, cluster of differentiation 36; CPT1b, carnitine palmitoyltransferase 1B; FA, fatty acid; FFA, free fatty acid; FGF, fibroblast growth factor; GK, glucokinase; GLUT, glucose transporter; GlyK, glycerol kinase; IRS2, insulin receptor substrate 1; LPL, lipoprotein lipase; NF-ÎºB, nuclear factor kappa-light-chain-enhancer of activated B cells; MCP-1, monocyte chemoattractant protein 1; MMP-9, matrix metalloproteinase 9; NO, nitric oxide; PAI-1, plasminogen activator inhibitor type 1; PCK2, peroxisome proliferator-activated receptor gamma 2 binding site; PEPCK, phosphoenolpyruvate carboxykinase; PI3K, phosphoinositide 3-kinase; PPARÎ³, peroxisome proliferator-activated receptor Î³; PPRE, peroxisome proliferator-activated receptor response element; RXR, retinoid X receptor; STAT6, signal transducer and activator of transcription 6; TG, triglyceride; TNF-Î±, tumor necrosis factor Î±; TZD, thiazolidinedione; VCAM-1, vascular cell adhesion molecule-1; VEGF, vascular endothelial growth factor.</p></div></div><p class="" id=d30534e312>From these studies, it seems that improvement of insulin sensitivity in liver and muscle might be secondary to the effects of TZDs in adipose tissue. However, there is also evidence showing that TZDs have an insulin-sensitizing effect on other peripheral organs. It has been demonstrated that ablation of liver PPARÎ³ in mice reduced hepatic steatosis but worsened hyperlipidemia, triglyceride clearance, and muscle insulin resistance<sup><a href="#ref-21">21</a></sup>. The expression of PPARÎ³ in skeletal muscle is relatively low compared to adipose tissue, and the physiological significance of PPARÎ³ in skeletal muscle has been shown to work indirectly in previous studies<sup><a href="#ref-22">22</a></sup>. However, selective activation of PPARÎ³ in skeletal muscle showed significant protection from high-fat diet-induced insulin resistance and associated changes in muscle phenotype, such as decreasing the quantity of lipid in myocytes and increasing the number of oxidative muscle fiber types<sup><a href="#ref-23">23</a></sup>. It suggests that the activation of PPARÎ³ can act directly on muscle tissue to improve insulin sensitivity. Macrophage PPARÎ³ is also implicated in anti-inflammation and lipid metabolism<sup><a href="#ref-24">24</a></sup>, and mice lacking macrophage PPARÎ³ are more prone to whole-body insulin resistance<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d30534e341>PPARÎ³ agonists and their effects on the vascular system: friend or foe?</h2><p class="" id=d30534e344>PPARÎ³ is expressed in the endothelium and vascular smooth muscle in the blood vessel wall<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. Despite controversial cardiovascular effects of TZDs in humans, most experimental studies showed beneficial effects on vascular systems. TZDs inhibit the proliferation and migration of vascular smooth muscle cells (VSMCs), with potential favorable effects on atherosclerosis<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Smooth muscle-specific dominant-negative PPARÎ³ transgenic mice showed a loss of nitric oxide responsiveness and high contractility<sup><a href="#ref-31">31</a></sup>, which resulted in systolic hypertension. In humans, dominant-negative mutations of PPARÎ³ are associated with early hypertension and insulin resistance<sup><a href="#ref-32">32</a></sup>. Activation of PPARÎ³ inhibits CCAAT/enhancer-binding protein-Î´ (C/EBPÎ´), which is a well-known mediator of the proinflammatory response in vascular cells<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d30534e373>TZDs also reduce activation and inflammation in endothelial cells by suppressing the expression of inflammation-associated genes<sup><a href="#ref-34">34</a>â<a href="#ref-37">37</a></sup>. On the other hand, TZDs induce vascular endothelial growth factor (VEGF) in endothelial cells and increase endothelial cell proliferation and migration by the Akt-dependent pathway<sup><a href="#ref-38">38</a>â<a href="#ref-40">40</a></sup>. In recent data, rosiglitazone significantly increased endothelial cell migration and vascular leakage in an animal study with increased VEGF expression and suppressed tight junction proteins, which caused instability of the endothelial membrane<sup><a href="#ref-41">41</a></sup>. This result could be related to vascular permeability, peripheral edema, and congestive heart failure associated with the use of TZDs, contrary to their beneficial effect on vascular cells. We still need more concrete evidence to understand the role of TZDs in the whole vascular system under various conditions.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d30534e397>Regulation of PPARÎ³ by PTMs to reduce the side effects of TZDs</h2><p class="" id=d30534e400>The PTM of PPARÎ³ involves several pathways, including phosphorylation, SUMOylation, ubiquitination, Î²-O-linked N-acetylglucosamine modification (O-GlcNAcylation), and acetylation. These PTMs are known to regulate both PPARÎ³ expression and its transcriptional activity<sup><a href="#ref-42">42</a></sup> and have been recently suggested as a good modality for reducing the side effects of PPARÎ³ activation by TZDs<sup><a href="#ref-43">43</a></sup> (<a href="#f2">Figure 2</a>).</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/15376/9ba0d516-292a-4325-a3e3-f3ebac85148d_figure2.gif"><img alt="9ba0d516-292a-4325-a3e3-f3ebac85148d_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/15376/9ba0d516-292a-4325-a3e3-f3ebac85148d_figure2.gif"></a><div class=caption><h3>Figure 2. Regulation of PPARÎ³ by post translational modification.</h3><p id=d30534e424>Ac, acetyl; ACSL1, acyl-CoA synthetase long chain family member 1; AF1, activation function 1; AF2, activation function 2; CD36, cluster of differentiation 36; Cdk, cyclin-dependent kinase; CPT1b, carnitine palmitoyltransferase 1B; DBD, DNA-binding domain; FABP3, fatty-acid-binding protein 3, muscle and heart; FAO, fatty acid oxidation; FGF, fibroblast growth factor; GlcNAC, N-acetylglucosamine; LBD, ligand-binding domain; Lys, lysine; MAPK, mitogen-activated protein kinase; P, phosphate; PPARÎ³, peroxisome proliferator-activated receptor Î³; PRDM16, PR domain containing 16; SENP2, small ubiquitin-like modifier-specific protease 2; Ser, serine; SIRT1, sirtuin 1; SUMO, small ubiquitin-like modifier; Thr, threonine; Ub, ubiquitin; WAT, white adipose tissue.</p></div></div><div class=section><a name=d30534e431 class=n-a></a><h3 class=section-title>Phosphorylation</h3><p class="" id=d30534e436>Phosphorylation at serine 112 (S112) in the N-terminal AF-1 domain was first identified, and various studies revealed that net results of PPARÎ³ phosphorylation may inhibit or stimulate its transcriptional activity depending on the cellular contexts and kinases involved<sup><a href="#ref-44">44</a>â<a href="#ref-48">48</a></sup>. Phosphorylation at S273 in the ligand-binding domain is mediated by cyclin-dependent kinase 5 (Cdk5), which is activated by pro-inflammatory stimuli and free fatty acids<sup><a href="#ref-49">49</a></sup>. S273 phosphorylation affects the expression of insulin-sensitizing adipokines such as adiponectin and adipsin but not those affecting adipogenesis. PPARÎ³ partial agonist MRL24 specifically blocks the phosphorylation of PPARÎ³ at S273 and has higher anti-diabetic activity and fewer side effects than does rosiglitazone<sup><a href="#ref-49">49</a></sup>. SR1664 and similar non-agonist PPARÎ³ ligands were also developed for blocking cdk5-mediated phosphorylation and showed improved insulin sensitivity in high-fat diet-fed mice without causing side effects such as fluid retention and weight gain<sup><a href="#ref-43">43</a>,<a href="#ref-50">50</a></sup>. More recently, it has been reported that phosphorylation at S273 is also facilitated by MEK/ERK, and inhibition of MEK and ERK improves insulin resistance, suggesting that MEK and ERK inhibitors can be therapeutic targets for diabetes through the modulation of PPARÎ³ function<sup><a href="#ref-51">51</a></sup>.</p></div><div class=section><a name=d30534e466 class=n-a></a><h3 class=section-title>SUMOylation</h3><p class="" id=d30534e471>Small ubiquitin-like modifier (SUMO) modification is a reversible process and may affect protein stability, transcriptional activity, and proteinâprotein interaction. PPARÎ³ is known as a target of SUMOylation. Lysine 107 (K107) of PPARÎ³2 is the major SUMOylation site, and deSUMOylation of this site increases the transcriptional activity of PPARÎ³<sup><a href="#ref-52">52</a></sup>. The K107R mutant form of PPARÎ³ stimulates adipogenesis and suppresses neointimal formation after balloon injury more effectively than does the PPARÎ³ wild-type form<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. SUMOylation at K107 of PPARÎ³ may be linked to S112 phosphorylation<sup><a href="#ref-53">53</a></sup>. PPARÎ³ SUMOylation at K107 is markedly increased in FGF21-knockout mice, suggesting that FGF21 regulates PPARÎ³ SUMOylation by an unknown mechanism<sup><a href="#ref-19">19</a></sup>. SUMOylation of PPARÎ³ at K395 (K365 of PPARÎ³1) is stimulated by PPARÎ³ agonists, and this modification inhibits the transcription of inflammatory response genes, such as <i>iNOS</i>, through recruiting transcriptional repressors to the NFkB complex in macrophages<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d30534e501>SUMO-specific protease 2 (SENP2) is the major deSUMOylation enzyme of PPARÎ³<sup><a href="#ref-56">56</a></sup>. Overexpression of SENP2 in C2C12 cells effectively induces PPARÎ³ target genes such as <i>Fabp3</i> and <i>Cd36</i> but not <i>Adrp</i>; thus, SENP2 can induce the expression of PPARÎ³ target genes in a selective manner<sup><a href="#ref-56">56</a></sup>. SENP2 deSUMOylates PPARÎ³ and PPARÎ´ and activates genes involved in fatty acid oxidation such as <i>Cpt1b</i> and <i>Acsl1</i>, which results in an increase of fatty acid oxidation in muscle. Interestingly, palmitate increases SENP2 expression via the TLR4-MyD88-NFkB pathway. These results suggest that SENP2 is an important regulator of fatty acid metabolism in skeletal muscle<sup><a href="#ref-57">57</a></sup>.</p></div><div class=section><a name=d30534e534 class=n-a></a><h3 class=section-title>Ubiquitination</h3><p class="" id=d30534e539>Ubiquitination is the covalent attachment of ubiquitin, a 76-amino-acid peptide, to lysine residues in the substrate protein. PPARÎ³ has a short half-life and is degraded by the polyubiquitin-proteasome pathway<sup><a href="#ref-58">58</a></sup>. Inhibition of proteasome activity by proteasome inhibitors increases PPARÎ³ stability, suggesting ubiquitin modification of PPARÎ³ is an important determinant of PPARÎ³ activity<sup><a href="#ref-58">58</a></sup>. Several ubiquitin ligases, such as FBOX9 and Cul4B, and an ubiquitin-specific protease (HAUSP) targeting PPARÎ³ have been identified, and an increase in PPARÎ³ stability generally promotes PPARÎ³ activity and adipogenesis<sup><a href="#ref-59">59</a>â<a href="#ref-61">61</a></sup>. Interestingly, PPARÎ³ agonists, TZDs, stimulate the ubiquitination of PPARÎ³, which can be mediated by an ubiquitin ligase, Siah1<sup><a href="#ref-58">58</a>,<a href="#ref-62">62</a></sup>. Therefore, PPARÎ³ ubiquitination may be differently regulated by several ubiquitin E3 ligases or proteases upon various conditions.</p></div><div class=section><a name=d30534e565 class=n-a></a><h3 class=section-title>O-GlcNAcylation</h3><p class="" id=d30534e570>O-GlcNAcylation is the post-translational cycling of a single Î²-O-linked N-acetylglucosamine (O-GlcNAc) on the hydroxyl groups of serine or threonine residues of target proteins. A major O-GlcNAc site in PPARÎ³ is T84 in the AF-1 domain in PPARÎ³2, and increased O-GlcNAcylation reduces its transcriptional activity and adipocyte differentiation<sup><a href="#ref-63">63</a></sup>.</p></div><div class=section><a name=d30534e578 class=n-a></a><h3 class=section-title>Acetylation</h3><p class="" id=d30534e583>Deacetylation at K268 and K293 by the NAD-dependent deacetylase sirtuin 1 (SIRT1) is necessary for the interaction of PPARÎ³ with PRDM16, a transcriptional co-activator for the browning of WAT<sup><a href="#ref-64">64</a></sup>. Therefore, SIRT1-dependent PPARÎ³ deacetylation selectively regulates PPARÎ³ activity.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d30534e594>Other PPARÎ³ modulators and agonists</h2><p class="" id=d30534e597>Considering that patients with insulin resistance show many conjugated metabolic problems such as atherosclerosis, obesity, fatty liver, etc., there have been many efforts to develop sPPAR<i>Î³</i>Ms, dual or pan PPAR agonists, with potent efficacy but less-deleterious side effects.</p><p class="" id=d30534e603>sPPAR<i>Î³</i>Ms bind to the ligand-binding domain of PPARÎ³ in many ways, which leads to different receptor conformations and cofactor functions<sup><a href="#ref-65">65</a></sup>. INT131, a potent non-TZD sPPARÎ³M now in clinical trials, showed excellent glucose lowering with significantly less weight gain, edema with fluid retention, and cardiomegaly than do current TZDs<sup><a href="#ref-66">66</a></sup>. Balaglitazone also showed positive effects in the treatment of patients with type 2 diabetes compared to placebo and pioglitazone (phase III clinical study, n = 409), better glycemic control, and less edema compared to pioglitazone 45 mg<sup><a href="#ref-67">67</a></sup>. CMHX008 was also tested for its effects in <i>in vitro</i> and <i>in vivo</i> models, showing excellent results by far<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d30534e632>PPARÎ±/Î³ dual activation has been the focus of new targets from many pharmaceutical companies, and several clinical trials have been performed in potential treatments such as muraglitazar, tesaglitazar, and aleglitazar. However, owing to unpredictable side effects, the studies were all stopped for further development. Unfortunately, muraglitazar increased cardiovascular events, tesaglitazar increased renal toxicity, and aleglitazar showed bone fractures, heart failure, and gastrointestinal side effects<sup><a href="#ref-69">69</a>â<a href="#ref-71">71</a></sup>. Recently, (E)-N-(4-(3-(5-bromo-4-hydroxy-2-methoxyphenyl)acryloyl)phenyl)-4-<i>tert</i>-butylbenzamide (SN158) showed anti-diabetic effects through PPARÎ±/Î³ dual activation. SN158 increased adipogenic differentiation of 3T3-L1 preadipocytes, enhanced fatty acid oxidation in hepatocytes, and increased glucose uptake in myotubes. It lowered plasma glucose and lipid levels in ob/ob mice without severe weight gain. Thus, it represents another candidate PPARÎ±/Î³ agonist to enhance many metabolic profiles in obesity-related diseases<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d30534e649>There are some natural products which activate PPARÎ³ and PPARÎ± simultaneously or activate the PPARÎ³ dimer partner retinoid X receptor. Compared to full TZDs, these natural products usually show fewer side effects and comparable anti-diabetic effects<sup><a href="#ref-73">73</a></sup>. Honokiol, amorfrutin 1, amorfrutin B, amorphastilbol, genistein, biochanin A, sargaquinoic acid, sargahydroquinoic acid, resveratrol, etc. were tested for their efficacy in <i>in vitro</i> and <i>in vivo</i> studies<sup><a href="#ref-73">73</a></sup>.</p><p class="" id=d30534e667>The development of PPARÎ±/Î³/Î´ pan agonists as anti-diabetic, anti-obesity, or hypolipidemic drugs is still actively ongoing<sup><a href="#ref-74">74</a>,<a href="#ref-75">75</a></sup>. For example, IVA 337 is a potent and well-balanced pan PPAR agonist which showed promising results <i>in vitro</i> and <i>in vivo</i> and is expected to be used to treat patients with metabolic syndrome and non-alcoholic steatohepatitis<sup><a href="#ref-76">76</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d30534e691>Conclusion</h2><p class="" id=d30534e694>PPARÎ³ is still one of the most important targets for the treatment of insulin resistance and diabetes mellitus, even though current use of TZDs in clinical practice is limited because of undesirable adverse effects. Thus, novel strategies to modulate PPARÎ³ activity to enhance its beneficial effects and reduce unwanted side effects have been strongly anticipated. Recent advances in understanding how PTM of PPARÎ³ modulates PPARÎ³ activity provide novel ways to optimize PPARÎ³ activity with reduced adverse effects. In addition, selective PPARÎ³ modulators, dual or pan PPAR agonists, have been developed and tested for their metabolic effects in animal studies and in some clinical trials.</p><p class="" id=d30534e697>We hope safer PPARÎ³ agonists or modulators with excellent efficacy and fewer adverse effects will be available for treating metabolic diseases and insulin resistance in the near future.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d30534e1 class=n-a></a><h2 class=main-title id=d30781>Competing interests</h2><p class=metadata-entry><a name=d30534e133 class=n-a></a><p id=d30534e134> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d30534e1 class=n-a></a><h2 class=main-title id=d30783>Grant information</h2><p>This work was supported by National Research Foundation Grant by Ministry of Science and ICT, Republic of Korea (NRF-2016R1A2B3010373).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d30534e704 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d31041>References</h2><div class="section ref-list"><a name=d30534e704 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d30534e711 class=n-a></a>Laakso M, Kuusisto J: Insulin resistance and hyperglycaemia in cardiovascular disease development. <i>Nat Rev Endocrinol.</i> 2014; <b>10</b>(5): 293â302. <a target=xrefwindow id=d30534e719 href="http://www.ncbi.nlm.nih.gov/pubmed/24663222">PubMed Abstract </a> | <a target=xrefwindow id=d30534e722 href="http://dx.doi.org/10.1038/nrendo.2014.29">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d30534e731 class=n-a></a>Tontonoz P, Spiegelman BM: Fat and beyond: the diverse biology of PPARgamma. <i>Annu Rev Biochem.</i> 2008; <b>77</b>: 289â312. <a target=xrefwindow id=d30534e739 href="http://www.ncbi.nlm.nih.gov/pubmed/18518822">PubMed Abstract </a> | <a target=xrefwindow id=d30534e742 href="http://dx.doi.org/10.1146/annurev.biochem.77.061307.091829">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d30534e751 class=n-a></a>Ceriello A: Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. <i>Diabetes Metab Res Rev.</i> 2008; <b>24</b>(1): 14â26. <a target=xrefwindow id=d30534e759 href="http://www.ncbi.nlm.nih.gov/pubmed/17990280">PubMed Abstract </a> | <a target=xrefwindow id=d30534e762 href="http://dx.doi.org/10.1002/dmrr.790">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727132716"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e771 class=n-a></a>Lee M, Saver JL, Liao HW, <i> et al.</i>: Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis. <i>Stroke.</i> 2017; <b>48</b>(2): 388â93. <a target=xrefwindow id=d30534e782 href="http://www.ncbi.nlm.nih.gov/pubmed/27999139">PubMed Abstract </a> | <a target=xrefwindow id=d30534e785 href="http://dx.doi.org/10.1161/STROKEAHA.116.013977">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727132716">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d30534e798 class=n-a></a>Patel D, Walitt B, Lindsay J, <i> et al.</i>: Role of pioglitazone in the prevention of restenosis and need for revascularization after bare-metal stent implantation: a meta-analysis. <i>JACC Cardiovasc Interv.</i> 2011; <b>4</b>(3): 353â60. <a target=xrefwindow id=d30534e809 href="http://www.ncbi.nlm.nih.gov/pubmed/21435616">PubMed Abstract </a> | <a target=xrefwindow id=d30534e812 href="http://dx.doi.org/10.1016/j.jcin.2010.10.016">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729132320"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e822 class=n-a></a>Wang Z, Zhang T, Sun L, <i> et al.</i>: Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR. <i>PPAR Res.</i> 2016; <b>2016</b>: 7407153. <a target=xrefwindow id=d30534e833 href="http://www.ncbi.nlm.nih.gov/pubmed/27403152">PubMed Abstract </a> | <a target=xrefwindow id=d30534e836 href="http://dx.doi.org/10.1155/2016/7407153">Publisher Full Text </a> | <a target=xrefwindow id=d30534e840 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4923578">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729132320">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d30534e853 class=n-a></a>Choi D, Kim SK, Choi SH, <i> et al.</i>: Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. <i>Diabetes Care.</i> 2004; <b>27</b>(11): 2654â60. <a target=xrefwindow id=d30534e864 href="http://www.ncbi.nlm.nih.gov/pubmed/15505001">PubMed Abstract </a> | <a target=xrefwindow id=d30534e867 href="http://dx.doi.org/10.2337/diacare.27.11.2654">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d30534e876 class=n-a></a>Berlie HD, Kalus JS, Jaber LA: Thiazolidinediones and the risk of edema: a meta-analysis. <i>Diabetes Res Clin Pract.</i> 2007; <b>76</b>(2): 279â89. <a target=xrefwindow id=d30534e884 href="http://www.ncbi.nlm.nih.gov/pubmed/17055103">PubMed Abstract </a> | <a target=xrefwindow id=d30534e887 href="http://dx.doi.org/10.1016/j.diabres.2006.09.010">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1097180"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e896 class=n-a></a>Lago RM, Singh PP, Nesto RW: Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. <i>Lancet.</i> 2007; <b>370</b>(9593): 1129â36. <a target=xrefwindow id=d30534e904 href="http://www.ncbi.nlm.nih.gov/pubmed/17905165">PubMed Abstract </a> | <a target=xrefwindow id=d30534e907 href="http://dx.doi.org/10.1016/S0140-6736(07)61514-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1097180">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725587560"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e920 class=n-a></a>Billington EO, Grey A, Bolland MJ: The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis. <i>Diabetologia.</i> 2015; <b>58</b>(10): 2238â46. <a target=xrefwindow id=d30534e928 href="http://www.ncbi.nlm.nih.gov/pubmed/26109213">PubMed Abstract </a> | <a target=xrefwindow id=d30534e931 href="http://dx.doi.org/10.1007/s00125-015-3660-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725587560">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1086865"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e944 class=n-a></a>Nissen SE, Wolski K: Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. <i>N Engl J Med.</i> 2007; <b>356</b>(24): 2457â71. <a target=xrefwindow id=d30534e952 href="http://www.ncbi.nlm.nih.gov/pubmed/17517853">PubMed Abstract </a> | <a target=xrefwindow id=d30534e955 href="http://dx.doi.org/10.1056/NEJMoa072761">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1086865">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d30534e969 class=n-a></a>Fajas L, Auboeuf D, RaspÃ© E, <i> et al.</i>: The organization, promoter analysis, and expression of the human PPARgamma gene. <i>J Biol Chem.</i> 1997; <b>272</b>(30): 18779â89. <a target=xrefwindow id=d30534e980 href="http://www.ncbi.nlm.nih.gov/pubmed/9228052">PubMed Abstract </a> | <a target=xrefwindow id=d30534e983 href="http://dx.doi.org/10.1074/jbc.272.30.18779">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d30534e992 class=n-a></a>Ribon V, Johnson JH, Camp HS, <i> et al.</i>: Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the <i>CAP</i> gene. <i>Proc Natl Acad Sci U S A.</i> 1998; <b>95</b>(25): 14751â6. <a target=xrefwindow id=d30534e1006 href="http://www.ncbi.nlm.nih.gov/pubmed/9843961">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1010 href="http://dx.doi.org/10.1073/pnas.95.25.14751">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1013 href="http://www.ncbi.nlm.nih.gov/pmc/articles/24521">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d30534e1022 class=n-a></a>He W, Barak Y, Hevener A, <i> et al.</i>: Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. <i>Proc Natl Acad Sci U S A.</i> 2003; <b>100</b>(26): 15712â7. <a target=xrefwindow id=d30534e1033 href="http://www.ncbi.nlm.nih.gov/pubmed/14660788">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1036 href="http://dx.doi.org/10.1073/pnas.2536828100">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1040 href="http://www.ncbi.nlm.nih.gov/pmc/articles/307633">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d30534e1049 class=n-a></a>Chao L, Marcus-Samuels B, Mason MM, <i> et al.</i>: Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. <i>J Clin Invest.</i> 2000; <b>106</b>(10): 1221â8. <a target=xrefwindow id=d30534e1060 href="http://www.ncbi.nlm.nih.gov/pubmed/11086023">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1063 href="http://dx.doi.org/10.1172/JCI11245">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1067 href="http://www.ncbi.nlm.nih.gov/pmc/articles/381440">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d30534e1076 class=n-a></a>Peraldi P, Xu M, Spiegelman BM: Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. <i>J Clin Invest.</i> 1997; <b>100</b>(7): 1863â9. <a target=xrefwindow id=d30534e1084 href="http://www.ncbi.nlm.nih.gov/pubmed/9312188">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1087 href="http://dx.doi.org/10.1172/JCI119715">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1090 href="http://www.ncbi.nlm.nih.gov/pmc/articles/508373">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d30534e1099 class=n-a></a>Steppan CM, Bailey ST, Bhat S, <i> et al.</i>: The hormone resistin links obesity to diabetes. <i>Nature.</i> 2001; <b>409</b>(6818): 307â12. <a target=xrefwindow id=d30534e1110 href="http://www.ncbi.nlm.nih.gov/pubmed/11201732">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1113 href="http://dx.doi.org/10.1038/35053000">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d30534e1123 class=n-a></a>Berg AH, Combs TP, Du X, <i> et al.</i>: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. <i>Nat Med.</i> 2001; <b>7</b>(8): 947â53. <a target=xrefwindow id=d30534e1134 href="http://www.ncbi.nlm.nih.gov/pubmed/11479628">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1137 href="http://dx.doi.org/10.1038/90992">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13865958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e1146 class=n-a></a>Dutchak PA, Katafuchi T, Bookout AL, <i> et al.</i>: Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones. <i>Cell.</i> 2012; <b>148</b>(3): 556â67. <a target=xrefwindow id=d30534e1157 href="http://www.ncbi.nlm.nih.gov/pubmed/22304921">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1160 href="http://dx.doi.org/10.1016/j.cell.2011.11.062">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1164 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3273727">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13865958">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d30534e1177 class=n-a></a>Ye JM, Dzamko N, Cleasby ME, <i> et al.</i>: Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. <i>Diabetologia.</i> 2004; <b>47</b>(7): 1306â13. <a target=xrefwindow id=d30534e1188 href="http://www.ncbi.nlm.nih.gov/pubmed/15232684">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1191 href="http://dx.doi.org/10.1007/s00125-004-1436-1">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d30534e1200 class=n-a></a>Gavrilova O, Haluzik M, Matsusue K, <i> et al.</i>: Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. <i>J Biol Chem.</i> 2003; <b>278</b>(36): 34268â76. <a target=xrefwindow id=d30534e1211 href="http://www.ncbi.nlm.nih.gov/pubmed/12805374">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1214 href="http://dx.doi.org/10.1074/jbc.M300043200">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d30534e1223 class=n-a></a>Norris AW, Chen L, Fisher SJ, <i> et al.</i>: Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. <i>J Clin Invest.</i> 2003; <b>112</b>(4): 608â18. <a target=xrefwindow id=d30534e1234 href="http://www.ncbi.nlm.nih.gov/pubmed/12925701">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1237 href="http://dx.doi.org/10.1172/JCI17305">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1241 href="http://www.ncbi.nlm.nih.gov/pmc/articles/171387">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d30534e1250 class=n-a></a>Amin RH, Mathews ST, Camp HS, <i> et al.</i>: Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. <i>Am J Physiol Endocrinol Metab.</i> 2010; <b>298</b>(1): E28â37. <a target=xrefwindow id=d30534e1261 href="http://www.ncbi.nlm.nih.gov/pubmed/19843873">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1264 href="http://dx.doi.org/10.1152/ajpendo.00446.2009">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d30534e1274 class=n-a></a>Wahli W, Michalik L: PPARs at the crossroads of lipid signaling and inflammation. <i>Trends Endocrinol Metab.</i> 2012; <b>23</b>(7): 351â63. <a target=xrefwindow id=d30534e1282 href="http://www.ncbi.nlm.nih.gov/pubmed/22704720">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1285 href="http://dx.doi.org/10.1016/j.tem.2012.05.001">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717147862"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e1294 class=n-a></a>Hevener AL, Olefsky JM, Reichart D, <i> et al.</i>: Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. <i>J Clin Invest.</i> 2007; <b>117</b>(6): 1658â69. <a target=xrefwindow id=d30534e1305 href="http://www.ncbi.nlm.nih.gov/pubmed/17525798">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1308 href="http://dx.doi.org/10.1172/JCI31561">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1312 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1868788">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717147862">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1087775"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e1325 class=n-a></a>Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, <i> et al.</i>: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. <i>Nature.</i> 2007; <b>447</b>(7148): 1116â20. <a target=xrefwindow id=d30534e1336 href="http://www.ncbi.nlm.nih.gov/pubmed/17515919">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1339 href="http://dx.doi.org/10.1038/nature05894">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1343 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2587297">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1087775">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d30534e1356 class=n-a></a>Marx N, SchÃ¶nbeck U, Lazar MA, <i> et al.</i>: Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. <i>Circ Res.</i> 1998; <b>83</b>(11): 1097â103. <a target=xrefwindow id=d30534e1367 href="http://www.ncbi.nlm.nih.gov/pubmed/9831704">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1370 href="http://dx.doi.org/10.1161/01.RES.83.11.1097">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1374 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4231720">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d30534e1383 class=n-a></a>Xin X, Yang S, Kowalski J, <i> et al.</i>: Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis <i>in vitro</i> and <i>in vivo</i>. <i>J Biol Chem.</i> 1999; <b>274</b>(13): 9116â21. <a target=xrefwindow id=d30534e1401 href="http://www.ncbi.nlm.nih.gov/pubmed/10085162">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1404 href="http://dx.doi.org/10.1074/jbc.274.13.9116">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d30534e1413 class=n-a></a>Li AC, Brown KK, Silvestre MJ, <i> et al.</i>: Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. <i>J Clin Invest.</i> 2000; <b>106</b>(4): 523â31. <a target=xrefwindow id=d30534e1424 href="http://www.ncbi.nlm.nih.gov/pubmed/10953027">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1427 href="http://dx.doi.org/10.1172/JCI10370">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1431 href="http://www.ncbi.nlm.nih.gov/pmc/articles/380255">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d30534e1441 class=n-a></a>Lim S, Lee KS, Lee JE, <i> et al.</i>: Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis. <i>Atherosclerosis.</i> 2015; <b>243</b>(1): 107â19. <a target=xrefwindow id=d30534e1452 href="http://www.ncbi.nlm.nih.gov/pubmed/26363808">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1455 href="http://dx.doi.org/10.1016/j.atherosclerosis.2015.08.037">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d30534e1464 class=n-a></a>Halabi CM, Beyer AM, de Lange WJ, <i> et al.</i>: Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. <i>Cell Metab.</i> 2008; <b>7</b>(3): 215â26. <a target=xrefwindow id=d30534e1475 href="http://www.ncbi.nlm.nih.gov/pubmed/18316027">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1478 href="http://dx.doi.org/10.1016/j.cmet.2007.12.008">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1482 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2275166">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d30534e1491 class=n-a></a>Barroso I, Gurnell M, Crowley VE, <i> et al.</i>: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. <i>Nature.</i> 1999; <b>402</b>(6764): 880â3. <a target=xrefwindow id=d30534e1502 href="http://www.ncbi.nlm.nih.gov/pubmed/10622252">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1505 href="http://dx.doi.org/10.1038/47254">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d30534e1514 class=n-a></a>Takata Y, Kitami Y, Yang ZH, <i> et al.</i>: Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma. <i>Circ Res.</i> 2002; <b>91</b>(5): 427â33. <a target=xrefwindow id=d30534e1525 href="http://www.ncbi.nlm.nih.gov/pubmed/12215492">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1528 href="http://dx.doi.org/10.1161/01.RES.0000031271.20771.4F">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d30534e1537 class=n-a></a>Marx N, Mach F, Sauty A, <i> et al.</i>: Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. <i>J Immunol.</i> 2000; <b>164</b>(12): 6503â8. <a target=xrefwindow id=d30534e1548 href="http://www.ncbi.nlm.nih.gov/pubmed/10843708">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1551 href="http://dx.doi.org/10.4049/jimmunol.164.12.6503">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1555 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4231715">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d30534e1564 class=n-a></a>Jackson SM, Parhami F, Xi XP, <i> et al.</i>: Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. <i>Arterioscler Thromb Vasc Biol.</i> 1999; <b>19</b>(9): 2094â104. <a target=xrefwindow id=d30534e1575 href="http://www.ncbi.nlm.nih.gov/pubmed/10479650">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1578 href="http://dx.doi.org/10.1161/01.ATV.19.9.2094">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d30534e1588 class=n-a></a>Pasceri V, Wu HD, Willerson JT, <i> et al.</i>: Modulation of vascular inflammation <i>in vitro</i> and <i>in vivo</i> by peroxisome proliferator-activated receptor-gamma activators. <i>Circulation.</i> 2000; <b>101</b>(3): 235â8. <a target=xrefwindow id=d30534e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/10645917">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1609 href="http://dx.doi.org/10.1161/01.CIR.101.3.235">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d30534e1618 class=n-a></a>Hong HK, Cho YM, Park KH, <i> et al.</i>: Peroxisome proliferator-activated receptor gamma mediated inhibition of plasminogen activator inhibitor type 1 production and proliferation of human umbilical vein endothelial cells. <i>Diabetes Res Clin Pract.</i> 2003; <b>62</b>(1): 1â8. <a target=xrefwindow id=d30534e1629 href="http://www.ncbi.nlm.nih.gov/pubmed/14581151">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1632 href="http://dx.doi.org/10.1016/S0168-8227(03)00142-6">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d30534e1641 class=n-a></a>Dimmeler S, Dernbach E, Zeiher AM: Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. <i>FEBS Lett.</i> 2000; <b>477</b>(3): 258â62. <a target=xrefwindow id=d30534e1649 href="http://www.ncbi.nlm.nih.gov/pubmed/10908731">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1652 href="http://dx.doi.org/10.1016/S0014-5793(00)01657-4">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d30534e1661 class=n-a></a>Rikitake Y, Kawashima S, Yamashita T, <i> et al.</i>: Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. <i>Arterioscler Thromb Vasc Biol.</i> 2000; <b>20</b>(4): 1006â12. <a target=xrefwindow id=d30534e1672 href="http://www.ncbi.nlm.nih.gov/pubmed/10764665">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1675 href="http://dx.doi.org/10.1161/01.ATV.20.4.1006">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d30534e1684 class=n-a></a>Dimmeler S, Zeiher AM: Akt takes center stage in angiogenesis signaling. <i>Circ Res.</i> 2000; <b>86</b>(1): 4â5. <a target=xrefwindow id=d30534e1692 href="http://www.ncbi.nlm.nih.gov/pubmed/10625297">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1695 href="http://dx.doi.org/10.1161/01.RES.86.1.4">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d30534e1704 class=n-a></a>Ku YH, Cho BJ, Kim MJ, <i> et al.</i>: Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation. <i>BMC Pharmacol Toxicol.</i> 2017; <b>18</b>(1): 62. <a target=xrefwindow id=d30534e1715 href="http://www.ncbi.nlm.nih.gov/pubmed/28854981">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1718 href="http://dx.doi.org/10.1186/s40360-017-0169-y">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5577739">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d30534e1732 class=n-a></a>van Beekum O, Fleskens V, Kalkhoven E: Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator. <i>Obesity (Silver Spring).</i> 2009; <b>17</b>(2): 213â9. <a target=xrefwindow id=d30534e1740 href="http://www.ncbi.nlm.nih.gov/pubmed/19169221">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1743 href="http://dx.doi.org/10.1038/oby.2008.473">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d30534e1752 class=n-a></a>Choi SS, Kim ES, Koh M, <i> et al.</i>: A novel non-agonist peroxisome proliferator-activated receptor Î³ (PPARÎ³) ligand UHC1 blocks PPARÎ³ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity. <i>J Biol Chem.</i> 2014; <b>289</b>(38): 26618â29. <a target=xrefwindow id=d30534e1763 href="http://www.ncbi.nlm.nih.gov/pubmed/25100724">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1766 href="http://dx.doi.org/10.1074/jbc.M114.566794">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1770 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4176243">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d30534e1779 class=n-a></a>Hu E, Kim JB, Sarraf P, <i> et al.</i>: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. <i>Science.</i> 1996; <b>274</b>(5295): 2100â3. <a target=xrefwindow id=d30534e1790 href="http://www.ncbi.nlm.nih.gov/pubmed/8953045">PubMed Abstract </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d30534e1799 class=n-a></a>Adams M, Reginato MJ, Shao D, <i> et al.</i>: Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. <i>J Biol Chem.</i> 1997; <b>272</b>(8): 5128â32. <a target=xrefwindow id=d30534e1810 href="http://www.ncbi.nlm.nih.gov/pubmed/9030579">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1813 href="http://dx.doi.org/10.1074/jbc.272.8.5128">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d30534e1822 class=n-a></a>Shao D, Rangwala SM, Bailey ST, <i> et al.</i>: Interdomain communication regulating ligand binding by PPAR-gamma. <i>Nature.</i> 1998; <b>396</b>(6709): 377â80. <a target=xrefwindow id=d30534e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/9845075">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1836 href="http://dx.doi.org/10.1038/24634">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d30534e1845 class=n-a></a>Rangwala SM, Rhoades B, Shapiro JS, <i> et al.</i>: Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. <i>Dev Cell.</i> 2003; <b>5</b>(4): 657â63. <a target=xrefwindow id=d30534e1856 href="http://www.ncbi.nlm.nih.gov/pubmed/14536066">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1859 href="http://dx.doi.org/10.1016/S1534-5807(03)00274-0">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d30534e1869 class=n-a></a>Compe E, DranÃ© P, Laurent C, <i> et al.</i>: Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations. <i>Mol Cell Biol.</i> 2005; <b>25</b>(14): 6065â76. <a target=xrefwindow id=d30534e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/15988019">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1883 href="http://dx.doi.org/10.1128/MCB.25.14.6065-6076.2005">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1887 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1168804">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4305956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e1896 class=n-a></a>Choi JH, Banks AS, Estall JL, <i> et al.</i>: Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. <i>Nature.</i> 2010; <b>466</b>(7305): 451â6. <a target=xrefwindow id=d30534e1907 href="http://www.ncbi.nlm.nih.gov/pubmed/20651683">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1910 href="http://dx.doi.org/10.1038/nature09291">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2987584">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4305956">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13238956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e1927 class=n-a></a>Choi JH, Banks AS, Kamenecka TM, <i> et al.</i>: Antidiabetic actions of a non-agonist PPARÎ³ ligand blocking Cdk5-mediated phosphorylation. <i>Nature.</i> 2011; <b>477</b>(7365): 477â81. <a target=xrefwindow id=d30534e1938 href="http://www.ncbi.nlm.nih.gov/pubmed/21892191">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1941 href="http://dx.doi.org/10.1038/nature10383">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1945 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3179551">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13238956">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725241214"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e1958 class=n-a></a>Banks AS, McAllister FE, Camporez JP, <i> et al.</i>: An ERK/Cdk5 axis controls the diabetogenic actions of PPARÎ³. <i>Nature.</i> 2015; <b>517</b>(7534): 391â5. <a target=xrefwindow id=d30534e1969 href="http://www.ncbi.nlm.nih.gov/pubmed/25409143">PubMed Abstract </a> | <a target=xrefwindow id=d30534e1972 href="http://dx.doi.org/10.1038/nature13887">Publisher Full Text </a> | <a target=xrefwindow id=d30534e1976 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4297557">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725241214">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d30534e1989 class=n-a></a>Ohshima T, Koga H, Shimotohno K: Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification. <i>J Biol Chem.</i> 2004; <b>279</b>(28): 29551â7. <a target=xrefwindow id=d30534e1997 href="http://www.ncbi.nlm.nih.gov/pubmed/15123625">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2000 href="http://dx.doi.org/10.1074/jbc.M403866200">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d30534e2009 class=n-a></a>Yamashita D, Yamaguchi T, Shimizu M, <i> et al.</i>: The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain. <i>Genes Cells.</i> 2004; <b>9</b>(11): 1017â29. <a target=xrefwindow id=d30534e2020 href="http://www.ncbi.nlm.nih.gov/pubmed/15507114">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2023 href="http://dx.doi.org/10.1111/j.1365-2443.2004.00786.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d30534e2033 class=n-a></a>Lim S, Ahn BY, Chung SS, <i> et al.</i>: Effect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats. <i>Atherosclerosis.</i> 2009; <b>206</b>(2): 411â7. <a target=xrefwindow id=d30534e2044 href="http://www.ncbi.nlm.nih.gov/pubmed/19339015">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2047 href="http://dx.doi.org/10.1016/j.atherosclerosis.2009.02.031">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1027784"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2056 class=n-a></a>Pascual G, Fong AL, Ogawa S, <i> et al.</i>: A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. <i>Nature.</i> 2005; <b>437</b>(7059): 759â63. <a target=xrefwindow id=d30534e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/16127449">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2070 href="http://dx.doi.org/10.1038/nature03988">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2074 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1464798">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1027784">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d30534e2087 class=n-a></a>Chung SS, Ahn BY, Kim M, <i> et al.</i>: SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor Î³ in C2C12 myotubes. <i>Biochem J.</i> 2011; <b>433</b>(1): 155â61. <a target=xrefwindow id=d30534e2098 href="http://www.ncbi.nlm.nih.gov/pubmed/20950277">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2101 href="http://dx.doi.org/10.1042/BJ20100749">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d30534e2110 class=n-a></a>Koo YD, Choi JW, Kim M, <i> et al.</i>: SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle. <i>Diabetes.</i> 2015; <b>64</b>(7): 2420â31. <a target=xrefwindow id=d30534e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/25784542">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2124 href="http://dx.doi.org/10.2337/db15-0115">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2128 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4477359">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d30534e2137 class=n-a></a>Hauser S, Adelmant G, Sarraf P, <i> et al.</i>: Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. <i>J Biol Chem.</i> 2000; <b>275</b>(24): 18527â33. <a target=xrefwindow id=d30534e2148 href="http://www.ncbi.nlm.nih.gov/pubmed/10748014">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2151 href="http://dx.doi.org/10.1074/jbc.M001297200">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d30534e2160 class=n-a></a>Lee KW, Kwak SH, Koo YD, <i> et al.</i>: F-box only protein 9 is an E3 ubiquitin ligase of PPARÎ³. <i>Exp Mol Med.</i> 2016; <b>48</b>: e234. <a target=xrefwindow id=d30534e2171 href="http://www.ncbi.nlm.nih.gov/pubmed/27197753">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2174 href="http://dx.doi.org/10.1038/emm.2016.31">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2178 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4910150">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727054031"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2188 class=n-a></a>Li P, Song Y, Zan W, <i> et al.</i>: Lack of CUL4B in Adipocytes Promotes PPARÎ³-Mediated Adipose Tissue Expansion and Insulin Sensitivity. <i>Diabetes.</i> 2017; <b>66</b>: 300â13. <a target=xrefwindow id=d30534e2199 href="http://www.ncbi.nlm.nih.gov/pubmed/27899484">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2202 href="http://dx.doi.org/10.2337/db16-0743">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727054031">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d30534e2215 class=n-a></a>Lee KW, Cho JG, Kim CM, <i> et al.</i>: Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor Î³ (PPARÎ³) stability through its deubiquitinating activity. <i>J Biol Chem.</i> 2013; <b>288</b>(46): 32886â96. <a target=xrefwindow id=d30534e2226 href="http://www.ncbi.nlm.nih.gov/pubmed/24072712">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2229 href="http://dx.doi.org/10.1074/jbc.M113.496331">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2233 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3829140">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d30534e2242 class=n-a></a>Kilroy G, Kirk-Ballard H, Carter LE, <i> et al.</i>: The ubiquitin ligase Siah2 regulates PPARÎ³ activity in adipocytes. <i>Endocrinology.</i> 2012; <b>153</b>(3): 1206â18. <a target=xrefwindow id=d30534e2253 href="http://www.ncbi.nlm.nih.gov/pubmed/22294748">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2256 href="http://dx.doi.org/10.1210/en.2011-1725">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2260 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3281538">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d30534e2269 class=n-a></a>Ji S, Park SY, Roth J, <i> et al.</i>: <i>O</i>-GlcNAc modification of PPARÎ³ reduces its transcriptional activity. <i>Biochem Biophys Res Commun.</i> 2012; <b>417</b>(4): 1158â63. <a target=xrefwindow id=d30534e2283 href="http://www.ncbi.nlm.nih.gov/pubmed/22226965">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2287 href="http://dx.doi.org/10.1016/j.bbrc.2011.12.086">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717953501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2296 class=n-a></a>Qiang L, Wang L, Kon N, <i> et al.</i>: Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of PparÎ³. <i>Cell.</i> 2012; <b>150</b>(3): 620â32. <a target=xrefwindow id=d30534e2307 href="http://www.ncbi.nlm.nih.gov/pubmed/22863012">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2310 href="http://dx.doi.org/10.1016/j.cell.2012.06.027">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3413172">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717953501">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d30534e2327 class=n-a></a>Higgins LS, Depaoli AM: Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. <i>Am J Clin Nutr.</i> 2010; <b>91</b>(1): 267Sâ72. <a target=xrefwindow id=d30534e2335 href="http://www.ncbi.nlm.nih.gov/pubmed/19906796">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2338 href="http://dx.doi.org/10.3945/ajcn.2009.28449E">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718347142"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2348 class=n-a></a>Depaoli AM, Higgins LS, Henry RR, <i> et al.</i>: Can a selective PPARÎ³ modulator improve glycemic control in patients with type 2 diabetes with fewer side effects compared with pioglitazone? <i>Diabetes Care.</i> 2014; <b>37</b>(7): 1918â23. <a target=xrefwindow id=d30534e2359 href="http://www.ncbi.nlm.nih.gov/pubmed/24722496">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2362 href="http://dx.doi.org/10.2337/dc13-2480">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718347142">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d30534e2375 class=n-a></a>Henriksen K, Byrjalsen I, Qvist P, <i> et al.</i>: Efficacy and safety of the PPARÎ³ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy. <i>Diabetes Metab Res Rev.</i> 2011; <b>27</b>(4): 392â401. <a target=xrefwindow id=d30534e2386 href="http://www.ncbi.nlm.nih.gov/pubmed/21328517">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2389 href="http://dx.doi.org/10.1002/dmrr.1187">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d30534e2398 class=n-a></a>Ming Y, Hu X, Song Y, <i> et al.</i>: CMHX008, a novel peroxisome proliferator-activated receptor Î³ partial agonist, enhances insulin sensitivity <i>in vitro</i> and <i>in vivo</i>. <i>PLoS One.</i> 2014; <b>9</b>(7): e102102. <a target=xrefwindow id=d30534e2416 href="http://www.ncbi.nlm.nih.gov/pubmed/25004107">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2419 href="http://dx.doi.org/10.1371/journal.pone.0102102">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2422 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4087031">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d30534e2431 class=n-a></a>Nissen SE, Wolski K, Topol EJ: Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. <i>JAMA.</i> 2005; <b>294</b>(20): 2581â6. <a target=xrefwindow id=d30534e2439 href="http://www.ncbi.nlm.nih.gov/pubmed/16239637">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2442 href="http://dx.doi.org/10.1001/jama.294.20.joc50147">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d30534e2451 class=n-a></a>Goldstein BJ, Rosenstock J, Anzalone D, <i> et al.</i>: Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial. <i>Curr Med Res Opin.</i> 2006; <b>22</b>(12): 2575â90. <a target=xrefwindow id=d30534e2462 href="http://www.ncbi.nlm.nih.gov/pubmed/17166340">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2465 href="http://dx.doi.org/10.1185/030079906X154169">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d30534e2474 class=n-a></a>Lincoff AM, Tardif JC, Schwartz GG, <i> et al.</i>: Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial. <i>JAMA.</i> 2014; <b>311</b>(5): 1515â25. <a target=xrefwindow id=d30534e2485 href="http://www.ncbi.nlm.nih.gov/pubmed/24682069">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2488 href="http://dx.doi.org/10.1001/jama.2014.3321">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727552139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2498 class=n-a></a>Jung Y, Cao Y, Paudel S, <i> et al.</i>: Antidiabetic effect of SN158 through PPARÎ±/Î³ dual activation in <i>ob/ob</i> mice. <i>Chem Biol Interact.</i> 2017; <b>268</b>: 24â30. <a target=xrefwindow id=d30534e2512 href="http://www.ncbi.nlm.nih.gov/pubmed/28242381">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2516 href="http://dx.doi.org/10.1016/j.cbi.2017.02.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727552139">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d30534e2529 class=n-a></a>Wang L, Waltenberger B, Pferschy-Wenzig EM, <i> et al.</i>: Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARÎ³): a review. <i>Biochem Pharmacol.</i> 2014; <b>92</b>(1): 73â89. <a target=xrefwindow id=d30534e2540 href="http://www.ncbi.nlm.nih.gov/pubmed/25083916">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2543 href="http://dx.doi.org/10.1016/j.bcp.2014.07.018">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2547 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4212005">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733639208"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2556 class=n-a></a>An HJ, Lee B, Kim SM, <i> et al.</i>: A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation. <i>Biol Pharm Bull.</i> 2018; <b>41</b>(1): 29â35. <a target=xrefwindow id=d30534e2567 href="http://www.ncbi.nlm.nih.gov/pubmed/29311481">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2570 href="http://dx.doi.org/10.1248/bpb.b17-00371">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733639208">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727389368"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2583 class=n-a></a>Huang Y, Powers C, Moore V, <i> et al.</i>: The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. <i>Orphanet J Rare Dis.</i> 2017; <b>12</b>(1): 49. <a target=xrefwindow id=d30534e2594 href="http://www.ncbi.nlm.nih.gov/pubmed/28279226">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2597 href="http://dx.doi.org/10.1186/s13023-017-0605-5">Publisher Full Text </a> | <a target=xrefwindow id=d30534e2601 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5345250">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727389368">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732674530"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d30534e2614 class=n-a></a>Boubia B, Poupardin O, Barth M, <i> et al.</i>: Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) Î±/Î³/Î´ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate. <i>J Med Chem.</i> 2018; <b>61</b>(6): 2246â65. <a target=xrefwindow id=d30534e2625 href="http://www.ncbi.nlm.nih.gov/pubmed/29446942">PubMed Abstract </a> | <a target=xrefwindow id=d30534e2628 href="http://dx.doi.org/10.1021/acs.jmedchem.7b01285">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732674530">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1127.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1127.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea<br/> <sup>2</sup> Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea<br/> <sup>3</sup> Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea<br/> <sup>4</sup> Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea<br/> <p> <div class=margin-bottom> Sung Hee Choi <br/> <span>Roles: </span> Conceptualization, Data Curation, Resources, Writing â Original Draft Preparation, Writing â Review & Editing </div> <div class=margin-bottom> Sung Soo Chung <br/> <span>Roles: </span> Conceptualization, Data Curation, Resources, Supervision, Writing â Original Draft Preparation </div> <div class=margin-bottom> Kyong Soo Park <br/> <span>Roles: </span> Conceptualization, Data Curation, Resources, Supervision, Writing â Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1127/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 24 Jul 2018, 7:1127 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14136.1">https://doi.org/10.12688/f1000research.14136.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> Â© 2018 Choi SH <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15376 data-id=14136 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14136.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1127/v1/pdf?article_uuid=02685d68-731b-4012-b91c-ee876623d22c" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14136.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Choi SH, Chung SS and Park KS. Re-highlighting the action of PPARÎ³ in treating metabolic diseases [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1127 (<a href="https://doi.org/10.12688/f1000research.14136.1" target=_blank>https://doi.org/10.12688/f1000research.14136.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14136 id=mobile-track-article-signin-14136 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14136?target=/articles/7-1127.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15376 /> <input name=articleId type=hidden value=14136 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Laszlo Nagy</strong>, SBP Medical Discovery Institute, USA; Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Attila Pap</strong>, Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Alexander Orekhov</strong>, Institute for Atherosclerosis Research, Skolkovo Innovative Center, Russian Federation </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1127.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1127.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36609-36080></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20010-36081></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1127/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>24 Jul 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Laszlo Nagy</strong>, SBP Medical Discovery Institute, USA; Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Attila Pap</strong>, Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Alexander Orekhov</strong>, Institute for Atherosclerosis Research, Skolkovo Innovative Center, Russian Federation </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1127.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1127/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Re-highlighting the action of PPAR\u03B3...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1127/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1127/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1127/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Choi SH et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1127/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1127",
            templates : {
                twitter : "Re-highlighting the action of PPAR\u03B3 in treating metabolic.... Choi SH et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1127/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Re-highlighting the action of PPAR\u03B3 in treating metabolic diseases", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Re-highlighting the action of PPAR\u03B3 in treating metabolic diseases", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14136/15376")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15376");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "36080": 0,
                           "36081": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "17269ac8-3437-4d96-b851-da4abfea4416";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1127.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1127.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1127.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1127.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1127.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>